miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18525125 Alzheimer disease, susceptibility to - 104300 Neurological hippocampus miRNA overexpression - - - Patient study phenotype-phenotype quantitative PCR
18923441 Cancer - 0 (Leukemia, acute lymphoblastic - 0) Cancer blood miRNA overexpression - 1.48 - Patient study phenotype-control quantitative PCR
18923441 Cancer - 0 (Leukemia, acute lymphoblastic - 0) Cancer blood miRNA overexpression - 2.53 - Patient study phenotype-control quantitative PCR
17606841 Cardiomyopathy, dilated - 115200 Cardiovascular left ventricle miRNA overexpression - 5.06 - Patient study phenotype-control miRNA microarray
17606841 - - left ventricle miRNA downregulation - 4.59 - Bioprocess study miRNA microarray
17942673 Duchenne muscular dystrophy - 310200 Muscular muscle miRNA downregulation - 1.56 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 1.77 - Patient study phenotype-control miRNA microarray
17712037 Supravalvar aortic stenosis - 185500 Cardiovascular myocardium miRNA overexpression - 1.37 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA downregulation - 1.20482 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - 1.44 - Cell culture study quantitative PCR
18182067 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.28205 - Patient study phenotype-control miRNA microarray
16754881 Ovarian cancer - 604370 Cancer ovary miRNA downregulation - - - Patient study phenotype-control array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA downregulation - 1.40845 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 1.5625 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 1.21 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 2.32558 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 3.125 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 4.34783 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 10.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA downregulation - 5.55556 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 1.05 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 1.53846 - Cell culture study quantitative PCR
18766170 Lung cancer - 211980 Cancer serum miRNA overexpression - 43.98 - Patient study phenotype-control deep sequencing
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 1.68 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA downregulation - 1.26582 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 1.27 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 1.14943 - Cell culture study quantitative PCR